agree with all the thinking to date.
IMO Jon and NEU are looking to do a few things for maximum value:
First as priority - prove NNZ for PhIII for a few select conditions;
Secondly, in parallel to the first objective - prove NNZ COULD be applied to multiple conditions, including Autism;
Lastly - end game - either partner or be acquired to see the true potential of NNZ
IMO Neurens main focus has to be PhIII - not Daybue revenue, share buybacks, dividends or any other frivolous stuff.
To date they have in my mind proven the POSSIBILITY of the 2nd objective (ie multiple conditions). Thats the LT carrot for any potential buyer.
Immediately, they now need to be seen as getting on with PhIII to really up the ante !
Share Price, page-11177
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.79 |
Change
-0.155(0.97%) |
Mkt cap ! $2.027B | |||
| Open | High | Low | Value | Volume |
| $16.25 | $16.32 | $15.75 | $6.648M | 416.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 167 | $15.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.79 | 826 | 10 |
View Market Depth
| Last trade - 14.22pm 14/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |